InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（8 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
8
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Klein Joseph III, Director. Insider active across 1 company, notably Ionis Pharmaceuticals INC. In total, 19 disclosures have been recorded. Split: 0 buy · 8 sells. Total volume traded: €2.6m. Activity tracked since 15 July 2021. The latest transaction was filed on 1 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Klein Joseph III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
11,518 股@ US$39.940.0034% mcap15.6% 占其流量Common StockSEC:0000874015-26-000229:0
99 股@ US$79.450.0001% mcap0.3% 占其流量Common StockSEC:0000874015-26-000229:1
11,419 股@ US$79.03940.0067% mcap30.5% 占其流量Common StockSEC:0000874015-26-000229:2
12,000 股@ US$38.068.2% 占其流量Common StockSEC:0000874015-26-000161:0
10,321 股@ US$41.087.6% 占其流量Common StockSEC:0000874015-26-000161:1
20,105 股@ US$75.50327.2% 占其流量Common StockSEC:0000874015-26-000161:2
2,216 股@ US$75.9543.0% 占其流量Common StockSEC:0000874015-26-000161:3
12,000 股@ US$40.050.0032% mcap50.0% 占其流量Common StockSEC:0000874015-26-000137:0
4,000 股0Common StockSEC:0000874015-25-000286:0
16,000 股0Common StockSEC:0000874015-25-000220:0
16,000 股0Common StockSEC:0000874015-25-000219:0
12,000 股@ US$24.4219.3% 占其流量Common StockSEC:0000874015-24-000180:0
1,318 股@ US$42.57213.8% 占其流量Common StockSEC:0000874015-24-000144:0
2,000 股@ US$50.006.6% 占其流量Common StockSEC:0000874015-23-000211:0
2,000 股@ US$45.12688.7% 占其流量Common StockSEC:0000874015-23-000196:0
1,777 股0Common StockSEC:0000874015-23-000176:0
2,000 股@ US$40.005.3% 占其流量Common StockSEC:0000874015-23-000046:0
5,333 股0Common StockSEC:0000874015-22-000140:0
5,333 股0Common StockSEC:0000874015-21-000136:0
19 条申报中的 19 条
About Klein Joseph III
Joseph Klein III is a Board Member at Ionis Pharmaceuticals Inc. He provides valuable expertise in corporate governance and strategy. His role on the board is essential for guiding strategic decisions and ensuring the company's regulatory compliance. Joseph Klein III is recognized for his ability to analyze market trends and advise on best management practices.
